Taken together, these results strongly support the assumption that the large family of TGF-β (TGF-β, BMP and activin/inhibin) plays dual roles in gestational trophoblastic diseases, and that the dual actions may depend on the stage of the pathology. This evidence concerns the gene TGFB1 and gestational trophoblastic neoplasm.